Podcasts Science The Elective Rotation: A Critical Care Hospital Pharmacy Podcast 677: Is there an efficacy tradeoff when reducing apixaban dose in patients with end-stage renal disease?

677: Is there an efficacy tradeoff when reducing apixaban dose in patients with end-stage renal disease?

Published: Jan. 10, 2022, 8 a.m.

b'Show notes at pharmacyjoe.com/episode677. In this episode, I\\u2019ll discuss the efficacy tradeoff when reducing apixaban dose in patients with end-stage renal disease.'